Biotech strategy and nanomedicine: the pharmaphorum podcastFor episode 5 of the pharmaphorum podcast Dominic Tyer met Blueberry Therapeutics’ CEO Dr John Ridden at The Share XBiotech strategy and nanomedicine: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/biotech-and-nanomedicine/
Commercialising orphan drugs: the pharmaphorum podcastIn episode 4 of the podcast pharmaphorum talked to Dr Joe Wiley, CEO of UK-based biopharmaceutical company Amryt Share XCommercialising orphan drugs: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/commercialising-orphan-drugs/
The future biosimilar landscape: the pharmaphorum podcastFor episode 3 of the pharmaphorum podcast Dominic Tyer went to the UK headquarters of Sandoz to meet Share XThe future biosimilar landscape: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/the-future-biosimilar-landscape/
Nimble consumer healthcare innovation: the pharmaphorum podcastIn episode 2 of the podcast pharmaphorum talked to the CEO of Infirst Healthcare Manfred Scheske about how Share XNimble consumer healthcare innovation: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/nimble-consumer-healthcare-innovation/
The pharmaphorum podcast: Patients versus Drug Prices (Episode 1)Available to download now – the very first pharmaphorum podcast. An interview with David Mitchell, Patients For Affordable Share XThe pharmaphorum podcast: Patients versus Drug Prices (Episode 1)https://pharmaphorum.com/podcast/the-pharmaphorum-podcast-patients-versus-drug-prices-episode-1/
